| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0264-410X(03)00341-4 |
| P698 | PubMed publication ID | 12850348 |
| P50 | author | Yvonne A. Maldonado | Q90471381 |
| Ann Arvin | Q4766238 | ||
| P2093 | author name string | Ross DeHovitz | |
| Hayley Gans | |||
| Bagher Forghani | |||
| Judith Beeler | |||
| P433 | issue | 24 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | measles | Q79793 |
| mumps | Q176741 | ||
| P304 | page(s) | 3398-3405 | |
| P577 | publication date | 2003-07-01 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life | |
| P478 | volume | 21 |
| Q81918606 | A recombinant live attenuated measles vaccine vector primes effective HLA-A0201-restricted cytotoxic T lymphocytes and broadly neutralizing antibodies against HIV-1 conserved epitopes |
| Q36378660 | Acquisition of maternal antibodies both from the placenta and by lactation protects mouse offspring from Yersinia pestis challenge |
| Q94555080 | Antibodies to human papillomavirus types 6, 11, 16 and 18: Vertical transmission and clearance in children up to two years of age |
| Q36999524 | Attenuated measles virus as a vaccine vector |
| Q57175801 | Beyond Passive Immunity: Is There Priming of the Fetal Immune System Following Vaccination in Pregnancy and What Are the Potential Clinical Implications? |
| Q36318008 | Biomarkers and assessment of vaccine responses |
| Q26700080 | Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination |
| Q38212484 | Challenges in vaccination of neonates, infants and young children |
| Q42269698 | Changes in the prevalence of the measles, rubella, varicella-zoster, and mumps virus antibody titers in Japanese pregnant women |
| Q90053805 | Cooperation of Oligodeoxynucleotides and Synthetic Molecules as Enhanced Immune Modulators |
| Q45422417 | Correlations among measles virus-specific antibody, lymphoproliferation and Th1/Th2 cytokine responses following measles-mumps-rubella-II (MMR-II) vaccination |
| Q34497669 | Danish children born with glutamic acid decarboxylase-65 and islet antigen-2 autoantibodies at birth had an increased risk to develop type 1 diabetes |
| Q90405355 | Development of a cumulative metric of vaccination adherence behavior and its application among a cohort of 12-month-olds in western Kenya |
| Q38209157 | Differential loss of humoral immunity against measles, mumps, rubella and varicella-zoster virus in children treated for cancer |
| Q90237843 | Effect of measles vaccination in infants younger than 9 months on the immune response to subsequent measles vaccine doses: a systematic review and meta-analysis |
| Q48031005 | Effectiveness of Jeryl Lynn-containing vaccine in Spanish children. |
| Q36312960 | Emerging diseases: measles |
| Q34378070 | Evaluating associations between vaccine response and malnutrition, gut function, and enteric infections in the MAL-ED cohort study: methods and challenges |
| Q81661574 | Follow-up of infants given measles vaccine at 6 months of age: antibody and CMI responses to MMRII at 15 months of age and antibody levels at 27 months of age |
| Q36284458 | HIV vaccines in infants and children |
| Q34601460 | High titers of circulating maternal antibodies suppress effector and memory B-cell responses induced by an attenuated rotavirus priming and rotavirus-like particle-immunostimulating complex boosting vaccine regimen |
| Q27025979 | IgG placental transfer in healthy and pathological pregnancies |
| Q36922479 | Immune responses to mumps vaccine in adults who were vaccinated in childhood |
| Q42242910 | Immunogenicity of a recombinant measles HIV-1 subtype C vaccine |
| Q38660625 | Impact of Early-Life Exposures to Infections, Antibiotics, and Vaccines on Perinatal and Long-term Health and Disease. |
| Q45787560 | Induction of neutralising antibodies and cellular immune responses against SARS coronavirus by recombinant measles viruses |
| Q42259895 | Induction of non-specific suppression in chicks by specific combination of maternal antibody and related antigen |
| Q34457996 | Induction of type I interferon secretion through recombinant Newcastle disease virus expressing measles virus hemagglutinin stimulates antibody secretion in the presence of maternal antibodies |
| Q28395364 | Influenza H1N1pdm-specific maternal antibodies offer limited protection against wild-type virus replication and influence influenza vaccination in ferrets |
| Q35067373 | Insights into the regulatory mechanism controlling the inhibition of vaccine-induced seroconversion by maternal antibodies |
| Q56880809 | Kinetics of maternal antibodies against rubella and varicella in infants |
| Q28074023 | Marek's disease in chickens: a review with focus on immunology |
| Q40596256 | Maternal anti-HBVs suppress the immune response of infants to hepatitis B vaccine. |
| Q38563384 | Maternal antibodies and infant immune responses to vaccines |
| Q33836970 | Maternal antibodies protect offspring from severe influenza infection and do not lead to detectable interference with subsequent offspring immunization |
| Q34193265 | Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies |
| Q82994029 | Maternal antibody inhibits both cellular and humoral immunity in response to measles vaccination at birth |
| Q56880800 | Maternal mumps antibodies in a cohort of children up to the age of 1 year |
| Q41992184 | Measles Antibodies in Mother-Infant Dyads in Tianjin, China. |
| Q57096187 | Measles antibodies and response to vaccination in children aged less than 14 months: implications for age of vaccination |
| Q34290874 | Measles outbreak in Europe: susceptibility of infants too young to be immunized. |
| Q35947792 | Measles virus-specific CD4 T-cell activity does not correlate with protection against lung infection or viral clearance |
| Q41020294 | Multi-disease analysis of maternal antibody decay using non-linear mixed models accounting for censoring |
| Q28272753 | Mumps |
| Q99711473 | Mumps Vaccines: Current Challenges and Future Prospects |
| Q38161438 | Neonatal immunology: responses to pathogenic microorganisms and epigenetics reveal an "immunodiverse" developmental state |
| Q35070880 | Nonhuman primate infants have an impaired respiratory but not systemic IgG antibody response following influenza virus infection |
| Q36880716 | Passive transmission and persistence of naturally acquired or vaccine-induced maternal antibodies against measles in newborns. |
| Q38392983 | Pertussis vaccination during pregnancy in Belgium: Follow-up of infants until 1 month after the fourth infant pertussis vaccination at 15 months of age. |
| Q35876806 | Placental Malaria: Decreased Transfer of Maternal Antibodies Directed to Plasmodium falciparum and Impact on the Incidence of Febrile Infections in Infants |
| Q44426709 | Placental transfer of measles antibodies: effect of gestational age and maternal vaccination status |
| Q36606717 | Poor immune responses of newborn rhesus macaques to measles virus DNA vaccines expressing the hemagglutinin and fusion glycoproteins |
| Q33768642 | Prevalence of protective measles virus antibody levels in umbilical cord blood samples in Catalonia, Spain |
| Q30359923 | Protection from SARS coronavirus conferred by live measles vaccine expressing the spike glycoprotein. |
| Q37404944 | Seroprevalences of Specific IgG Antibodies to Measles, Mumps, and Rubella in Korean Infants. |
| Q93161229 | Seroprevalences of antibodies against pertussis, diphtheria, tetanus, measles, mumps and rubella: A cross-sectional study in children following vaccination procedure in Guangzhou, China |
| Q45363598 | Sidestepping maternal antibody: a lesson from measles virus vaccination |
| Q34820590 | Synergistic induction of interferon α through TLR-3 and TLR-9 agonists stimulates immune responses against measles virus in neonatal cotton rats |
| Q38785828 | The Influence of Maternally Derived Antibody and Infant Age at Vaccination on Infant Vaccine Responses : An Individual Participant Meta-analysis. |
| Q91041800 | The effect of maternal antibodies on the cellular immune response after infant vaccination: A review |
| Q38048555 | The status of live viral vaccination in early life |
| Q36780156 | Use of viral vectors for the development of vaccines |
| Q34242179 | Vaccination of neonates: problem and issues |
| Q22305944 | Vaccination of the immunocompromised child |
| Q38269845 | Vaccines against respiratory viral pathogens for use in neonates: opportunities and challenges |
| Q76384978 | [Vaccines and pregnancy (part 2): protection of the newborn by vaccinating pregnant women] |
Search more.